Managing Cardiovascular Risk in Metastatic Breast Cancer Clinical Insights on CDK4/6 Inhibitors

This is Part 3 of Managing Cardiovascular Risk in Metastatic Breast Cancer: Clinical Insights on CDK4/6 Inhibitors, a three-part video roundtable series. Scroll down to watch the other videos from thi...

breast cancer

cardio-oncology

/ Managing Cardiovascular Risk in Metastatic Breast Cancer Clinical Insights on CDK4/6 Inhibitors

Case 2: CDK4/6 Inhibitor Choice in Medically Fragile Patients With Heart Failure

This is Part 2 of Managing Cardiovascular Risk in Metastatic Breast Cancer: Clinical Insights on CDK4/6 Inhibitors, a three-part video roundtable series. Scroll down to watch the other videos from thi...

breast cancer

cardio-oncology

/ Managing Cardiovascular Risk in Metastatic Breast Cancer Clinical Insights on CDK4/6 Inhibitors

Case 1: Management of Cardiovascular Risk Factors

This is Part 1 of Managing Cardiovascular Risk in Metastatic Breast Cancer: Clinical Insights on CDK4/6 Inhibitors, a three-part video roundtable series. Scroll down to watch the other videos from thi...

Managing Cardiovascular Risk in Metastatic Breast Cancer Clinical Insights on CDK4/6 Inhibitors

Case 3: Cardiac Risk Stratification

Case 2: CDK4/6 Inhibitor Choice in Medically Fragile Patients With Heart Failure

Case 1: Management of Cardiovascular Risk Factors

Understanding Accelerated Aging in Survivors of Childhood Cancers

Conversion of Unresectable Into Resectable Pancreatic Cancer: Chemoradiotherapy vs Chemotherapy

Do Breast and Gynecologic Cancers Contribute to Job Resignation in Working Women

Geriatric Assessment–Guided Approach to Treatment Intensity in Older Adults With AML

Gastrointestinal Tumor Microbes May Predict Prognosis and Therapeutic Response